B5ecd94c 0e1a 476c 940d 736ad4741a9c 01
Tadalafil Tablet, Film Coated
Product Images NDC 68180-914
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Tadalafil (NDC 68180-914). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Lupin Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
B5ecd94c 0e1a 476c 940d 736ad4741a9c 02
This text appears to be a table showing the maximal decrease in standing and supine systolic and diastolic blood pressure when tadalafil 20mg and tadalafil 10mg were co-administered with different drugs, including alcohol, alfuzosin, amiodipine, angiotensin II receptor blocker, doxazosin, tamsulosin, amlodipine, bendroflumethiazide, enalapril and metoprolol. The table also provides data on the mean difference in blood pressure between tadalafil and placebo.*
B5ecd94c 0e1a 476c 940d 736ad4741a9c 03
This is a drug interaction table that shows the effects of various co-administered drugs with Tadalafil. The drugs are categorized into CYP3A inhibitors, CYP3A inducers, antacids, and H2 antagonists. The effects are measured by AUC and Cmax values, fold change and 90% CIl. Depending on the effects, the recommendation may include dose adjustment or avoidance of co-administration.*
B5ecd94c 0e1a 476c 940d 736ad4741a9c 04
This is a list of drugs and their substrates that can be coadministered. The drugs are broken down by their associated CYP substrates, and their effects are measured as AUC (area under the concentration-time curve) or Cmax (maximum concentration). The drugs are also categorized by P-glycoprotein substrate, oral contraceptives, and NSAIDs. The last section provides recommendations for dose adjustment.*
B5ecd94c 0e1a 476c 940d 736ad4741a9c 05
B5ecd94c 0e1a 476c 940d 736ad4741a9c 06
This appears to be a table with information on the use of Bosentan and Tadalafil in subjects with Pulmonary Artery Hypertension (PAH). It includes data on the etiology of PAH, baseline WHO functional class, and the number of subjects in each group. There is also a comparison of the placebo-adjusted mean change in a 6-minute walk distance for those who received Tadalafil versus those who received a placebo. There are references to repaired shunts, but it is unclear how they relate to the study.*
B5ecd94c 0e1a 476c 940d 736ad4741a9c 07
B5ecd94c 0e1a 476c 940d 736ad4741a9c 08
This is a description for Tadalafil Tablets USP which contain 20mg of Tadalafil per tablet. The usual dosage is two 20mg tablets a day, taken once. The tablets should be taken as prescribed by a healthcare professional. The accompanying literature should be consulted for full dosing information. The tablets should be stored at room temperature between 15°C and 30°C. Lupin Pharmaceuticals Inc. manufactures these tablets in Baltimore, Maryland, and they are manufactured by Lupin Limited in Nagpur, India. The code number is MH/DRUGS/25-ND/59. The tablets should be kept out of reach of children and stored in a tight container.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
